Indian J Pharm Close
 

Table 3: Standar dose, indication and percentage of patients starting with the standard dose stated in the summary of product characteristics according to the tyrosine kinase inhibitor analyzed

Table 3: Standar dose, indication and percentage of patients starting with the standard dose stated in the summary of product characteristics according to the tyrosine kinase inhibitor analyzed